Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Clinical trial NCT06855498 · RECRUITING

Trial details

NCT number: NCT06855498
Sponsor: Incyte Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2025-02-28
Primary completion: 2028-02-28
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.